Steven D. Reich
Chief Medical OfficerDr. Steven D. Reich, MD serves as Chief Medical Officer at Artelo Biosciences, Inc since April 2018. Dr. Reich serves as Chief Executive Officer and Chief Medical Officer of Anaborex, Inc. Dr. Reich has over 30 years of drug research experience. Dr. Reich is a clinical development specialist with extensive experience in anticancer agents. Dr. Reich served as Chief Medical Officer and Senior Vice President of Attenuon, LLC. During the career, Dr. Reich has held senior-level positions responsible for Phase I through IV clinical research at biotechnology, pharmaceutical and contract research organizations including Biogen, Ligand, Parexel International, Pfizer and PharmaStem Therapeutics. Dr. Reich has participated as an academically-based investigator for Phase I-III trials and has designed and managed Phase I-IV trials for industrial sponsors. Dr. Reich served as Senior Vice President of Clinical Research of Ligand Pharmaceuticals since December 1995. Dr. Reich served as Senior Vice President of Medical Affairs at the clinical contract research organization PAREXEL International Corporation from 1987 to 1995. From 1986 to 1987, Dr. Reich served as worldwide Medical Research Director of Biogen, Inc. (Biogen). Dr. Reich held various positions at Biogen from 1983 to 1986. Dr. Reich served as Associate Director of Clinical Cancer Research of Bristol Laboratories from 1978 to 1979. Dr. Reich served as a Clinical Pharmacologist at Northwestern University, SUNY-Upstate Medical School and University of Massachusetts Medical Center. Dr. Reich is a Board certified Medical Oncologist trained at the Baltimore Cancer Research Center (NIH, NCI). Dr. Reich received an M.D from the New Jersey College of Medicine and an A.B. from Princeton University.
Positions
- Company NameArtelo Biosciences, Inc.Stock CodeARTLPositionChief Medical OfficerColleagues
- GDGregory D. GorgasPresident, CEO, Secretary & Director
- CLConnie L. MatsuiIndependent Chairperson of the Board
- MEMark E. SpringCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
- AYAndrew YatesSenior VP & Chief Scientific Officer
- JHJason H. BaybuttSenior Vice President of Finance
- SKSteven KellyIndependent Director
- DWDouglas W. BlayneyIndependent Director
- TATamara A. FavoritoIndependent Director
